Skip to primary content

Ketamine Leadership Academy

Ketamine Leadership Academy

Main menu

  • About and Disclaimer
  • Emergency-Medicine
  • Anaesthesia
  • Critical Care medicine
  • Pain Medicine
  • Prehospital and Retrieval Medicine
  • Psychiatry
  • Palliative Care medicine
  • Ketamine prescription in Australia
  • Introduction and History of Ketamine
  • The Politics of Medical Ketamine
  • Ketamine Music

Post navigation

← Previous Next →

2019 European statement on off label use of ketamine for depression

Posted on May 3, 2019 by ketaminh

Off-label use of ketamine for treatment-resistant depression in clinical practice: European perspective.
— Read on www.qxmd.com/r/31030677

Share this:

  • Print
  • Email

Like this:

Like Loading...

Related

This entry was posted in Psychiatry and tagged depression by ketaminh. Bookmark the permalink.

Ketamine Advocacy Network

Ketamine for Emergency Medicine

Creative Commons License
Ketamine Leadership Academy by Dr Minh Le Cong is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Blog at WordPress.com.
  • Follow Following
    • Ketamine Leadership Academy
      • Join 90 other followers
    • Already have a WordPress.com account? Log in now.
    • Ketamine Leadership Academy
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
%d bloggers like this: